STABLE LIQUID PREPARATION OF ANTIBODY Russian patent published in 2014 - IPC A61K38/00 A61K39/395 A61K31/00 A61K31/198 

Abstract RU 2518278 C2

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention refers to pharmaceutical preparations of antibodies, particularly to a stable liquid preparation of an antibody, and using the same. The invention represents the liquid preparation of the humanised nerve growth factor (NGF) antibody with the specified amino acid sequence presented in the description, containing both the antibody, and a tonicity agent, particularly trehalose, preferentially trehalose dihydrate, a histidine buffer, a chelating agent presenting EDTA, a surfactant - Polysorbate, preferentially Polysorbate 20 (PS20) taken in certain quantitative proportions. What is described is using the liquid composition of the antibody for preparing a therapeutic agent for treating NGF-mediated inflammatory and pain conditions in a mammal.

EFFECT: composition according to the invention possesses enhanced properties of stably maintaining high concentrations of the bioactive antibody in the solution, providing antibody aggregation, oxidation and fragmentation stability, as well as stable and effective antibody binding.

23 cl, 6 dwg, 16 tbl

Similar patents RU2518278C2

Title Year Author Number
METHODS OF OSTEOARTHRITIS PAIN MANAGEMENT BY ADMINISTRATION OF NERVE GROWTH FACTOR ANTAGONIST AND COMPOSITIONS CONTAINING IT 2006
  • Rozental' Arnon
  • Shelton Dehvid L.
  • Uolik Patritsija Ehnn
RU2429013C2
TREATMENT OF INTERSTITIAL CYSTITIS 2008
  • Millz Ajan Uill'Jam
  • Rozental' Arnon
  • Sholfild Dehvid Piter
  • Shelton Dehvid L'Juis
  • Fillips Stefen Charl'Z
RU2570559C2
STABLE PHARMACEUTICAL PREPARATION BASED ON THE PD-1 ANTIBODY AND ITS USE IN MEDICINE 2016
  • Li Tsze
  • Yan Chzhen
  • Van Pinpin
  • Fan Yan
  • Tao Vejkan
  • Chzhan Lyanshan
  • Sun Pyaoyan
RU2731418C2
HUMAN ANTIBODIES WITH HIGH AFFINITY TO HUMAN NERVE GROWTH FACTOR 2008
  • Rajnkhardt Dzhoehl K.
  • Makdonal'D Linn
  • Torres Richard
  • Morra Mark R.
  • Martin Dzhoehl Kh.
RU2473564C2
STABLE AQUEOUS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) ANTIBODY COMPOSITION 2016
  • Weiser Sarah Elizabeth
  • Ingram Rebecca Lee
RU2699544C2
STABLE BINDING PREPARATIONS BASED ON IgG4 2013
  • Yusiner Dirk
  • Yussef Akhmed
  • Khagendorf Annika
  • Kirsh Martina
  • Raggeberg Sabrina
  • Shniders Yuliya
RU2644214C2
PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY TO SOST, AND ITS USE 2018
  • Fang Jingjing
  • Yan Zhen
  • Liu Xun
RU2779430C2
CHIMERIC PROTEIN COMPOSED OF NGF ANTAGONIST DOMAIN AND TNFα ANTAGONIST DOMAIN 2015
  • Shofild Daren
  • Sliman Mettyu Aleksander
  • Chessell Ien Patrik
  • Khatcher Dzhonatan
  • Lou Devid
RU2678810C2
COMPOSITION OF CTLA-4 ANTIBODIES 2006
  • Ehbejt Dzhastin Donald
  • Das Tapan Kanti
  • Ehlliott Kehrri Mari
  • Mutkhurania Kevin Uomiti
  • Nema Sandip
  • Singkh Satish Kumar
RU2356579C1
PHARMACEUTICAL COMPOSITION 2017
  • Yates, Andrew Jeffrey
  • Massant, Jan Ivo
RU2775944C2

RU 2 518 278 C2

Authors

Badkar Advait Vidzhaj

Bokhehk Lejkh Kristen

King Kevin Rodzher

Lehri Alanta Lia

Dates

2014-06-10Published

2009-09-18Filed